XML 97 R86.htm IDEA: XBRL DOCUMENT v3.25.2
Earnings Per Common Share - EPS Under Basic and Diluted Computations (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net income $ 2,126 $ 1,332 $ 4,035 [1] $ 2,694 [1]
Preferred stock dividends and other (149) (121) (262) (232)
Net Income Available to Common Stockholders $ 1,977 $ 1,211 $ 3,773 $ 2,462
Weighted-average common shares outstanding - basic (in shares) 1,817 1,828 1,819 1,827
Basic earnings per share (in USD per share) [2] $ 1.09 $ 0.66 $ 2.07 $ 1.35
Weighted-average common shares outstanding - diluted (in shares) 1,822 1,834 1,825 1,832
Diluted earnings per share (in USD per share) [2] $ 1.08 $ 0.66 $ 2.07 $ 1.34
Antidilutive stock options and restricted stock awards excluded from the calculation of diluted EPS (in shares) 9 13 13 18
Common Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net income $ 2,126 $ 1,295 $ 4,017 $ 2,619
Preferred stock dividends and other (149) (118) (261) (226)
Net Income Available to Common Stockholders $ 1,977 $ 1,177 $ 3,756 $ 2,393
Weighted-average common shares outstanding - basic (in shares) 1,817 1,777 1,807 1,776
Basic earnings per share (in USD per share) $ 1.09 $ 0.66 $ 2.07 $ 1.35
Reallocation of net income available to common stockholders as a result of conversion of nonvoting to voting shares $ 0 $ 34 $ 17 $ 69
Allocation of net income available to common stockholders: $ 1,977 $ 1,211 $ 3,773 $ 2,462
Conversion of nonvoting shares to voting shares (in shares) 0 51 12 51
Common stock equivalent shares related to stock incentive plans (in shares) 5 6 6 5
Weighted-average common shares outstanding - diluted (in shares) 1,822 1,834 1,825 1,832
Diluted earnings per share (in USD per share) $ 1.08 $ 0.66 $ 2.07 $ 1.34
Nonvoting Common Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net income $ 0 $ 37 $ 18 $ 75
Preferred stock dividends and other 0 (3) (1) (6)
Net Income Available to Common Stockholders $ 0 $ 34 $ 17 $ 69
Weighted-average common shares outstanding - basic (in shares) 0 51 51 51
Basic earnings per share (in USD per share) $ 0 $ 0.66 $ 0.33 $ 1.35
Reallocation of net income available to common stockholders as a result of conversion of nonvoting to voting shares $ 0 $ 0 $ 0 $ 0
Allocation of net income available to common stockholders: $ 0 $ 34 $ 17 $ 69
Conversion of nonvoting shares to voting shares (in shares) 0 0 0 0
Common stock equivalent shares related to stock incentive plans (in shares) 0 0 0 0
Weighted-average common shares outstanding - diluted (in shares) 0 51 51 51
Diluted earnings per share (in USD per share) $ 0 $ 0.66 $ 0.33 $ 1.34
Consolidated Common Stock        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net income $ 2,126   $ 4,035  
Preferred stock dividends and other (149)   (262)  
Net Income Available to Common Stockholders $ 1,977   $ 3,773  
Weighted-average common shares outstanding - basic (in shares) 1,817   1,819  
Basic earnings per share (in USD per share) $ 1.09   $ 2.07  
Reallocation of net income available to common stockholders as a result of conversion of nonvoting to voting shares $ 0   $ 0  
Allocation of net income available to common stockholders: $ 1,977   $ 3,773  
Conversion of nonvoting shares to voting shares (in shares) 0   0  
Common stock equivalent shares related to stock incentive plans (in shares) 5   6  
Weighted-average common shares outstanding - diluted (in shares) 1,822   1,825  
Diluted earnings per share (in USD per share) $ 1.08   $ 2.07  
[1] Certain prior year amounts have been reclassified to conform to the current year presentation. See Note 1 for additional information.
[2] For additional information on earnings per common shares outstanding for both voting and nonvoting common stock, see Note 16.